Natasha Leskovsek
About Natasha
Natasha Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on US Food and Drug Administration regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies.
Passions
Providing practical compliance solutions at the intersection of science and regulation
I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.
Experience
-
MapLight Therapeutics Announces $258.9 Million IPO and Concurrent Private Placement
-
Adverum to Be Acquired by Lilly
-
Expedition Therapeutics Secures $165 Million Series A and Executes License Agreement With Fosun Pharma
-
Valneva Announces up to $500 Million Debt Facility With Pharmakon Advisors
-
Mabwell Bioscience Announces Formation of Kalexo Bio With Aditum Bio
Admissions and credentials
- District of Columbia
- Maryland
Memberships and affiliations
- Food and Drug Law Institute
Mental privacy at Cooley
Explore the legal and ethical frontiers of brain data and neural privacy
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.